| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study
|
Adeshara, Krishna A.
|
|
|
14 |
5 |
p. 1449-1458
|
artikel
|
| 2 |
Addressing gendered responses to dietary modifications among patients with type 2 diabetes mellitus
|
Chittem, Mahati
|
|
|
14 |
5 |
p. 1069
|
artikel
|
| 3 |
Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method
|
Maqbool, Annayath
|
|
|
14 |
5 |
p. 887-892
|
artikel
|
| 4 |
Analyzing COVID-19 pandemic for unequal distribution of tests, identified cases, deaths, and fatality rates in the top 18 countries
|
Shams, Shahbaz A.
|
|
|
14 |
5 |
p. 953-961
|
artikel
|
| 5 |
An android smartphone-based randomized intervention improves the quality of life in patients with type 2 diabetes in Mysore, Karnataka, India
|
Sunil Kumar, D.
|
|
|
14 |
5 |
p. 1327-1332
|
artikel
|
| 6 |
A novel peer-to-peer contact tracking application for COVID-19 and future pandemics
|
Brown, Nolan J.
|
|
|
14 |
5 |
p. 773-774
|
artikel
|
| 7 |
Antidepressant activity of anti-hyperglycemic agents in experimental models: A review
|
Essmat, Nariman
|
|
|
14 |
5 |
p. 1179-1186
|
artikel
|
| 8 |
Anti-hyperglycemic effect of the immature endosperm of sugar palm (Borassus flabellifer) fruit on type 2 diabetes mellitus patients-a case study
|
Rahman, Shaikh Shahinur
|
|
|
14 |
5 |
p. 1317-1322
|
artikel
|
| 9 |
Application of Artificial Intelligence in COVID-19 drug repurposing
|
Mohanty, Sweta
|
|
|
14 |
5 |
p. 1027-1031
|
artikel
|
| 10 |
Application of cognitive Internet of Medical Things for COVID-19 pandemic
|
Swayamsiddha, Swati
|
|
|
14 |
5 |
p. 911-915
|
artikel
|
| 11 |
Applications of industry 4.0 to overcome the COVID-19 operational challenges
|
Kumar, Mr Shashank
|
|
|
14 |
5 |
p. 1283-1289
|
artikel
|
| 12 |
A proposed ABCD scoring system for patient’s self assessment and at emergency department with symptoms of COVID-19
|
Salunke, Abhijeet Ashok
|
|
|
14 |
5 |
p. 1495-1501
|
artikel
|
| 13 |
ARIMA modelling & forecasting of COVID-19 in top five affected countries
|
Sahai, Alok Kumar
|
|
|
14 |
5 |
p. 1419-1427
|
artikel
|
| 14 |
Association between gravidity and risk of metabolic syndrome: Results of Tabari cohort study
|
Moosazadeh, Mahmood
|
|
|
14 |
5 |
p. 843-847
|
artikel
|
| 15 |
Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
|
Zaki, Nazar
|
|
|
14 |
5 |
p. 1133-1142
|
artikel
|
| 16 |
Association of Meteorin-Like Hormone with insulin resistance and body composition in healthy Iranian adults
|
Alizadeh, Hamid
|
|
|
14 |
5 |
p. 881-885
|
artikel
|
| 17 |
Association of serum regenerating islet-derived protein 3-beta and oncostatin-M levels with the risk of acute coronary syndrome in patients with type 2 diabetes mellitus – A pilot study
|
K, Midhuna
|
|
|
14 |
5 |
p. 1087-1092
|
artikel
|
| 18 |
A wave of non-communicable diseases following the COVID-19 pandemic
|
Lim, Michael Anthonius
|
|
|
14 |
5 |
p. 979-980
|
artikel
|
| 19 |
Balanced diet is a major casualty in COVID-19
|
Jayawardena, Ranil
|
|
|
14 |
5 |
p. 1085-1086
|
artikel
|
| 20 |
Blood glucose monitoring- an overview of current and future non-invasive devices
|
Bolla, Anmole S.
|
|
|
14 |
5 |
p. 739-751
|
artikel
|
| 21 |
BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank
|
Sattar, Naveed
|
|
|
14 |
5 |
p. 1149-1151
|
artikel
|
| 22 |
Burden of diabetic kidney disease among persons with type 2 diabetes mellitus registered in a tertiary care center, Puducherry
|
Rehman, Tanveer
|
|
|
14 |
5 |
p. 991-993
|
artikel
|
| 23 |
Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19
|
Mahajan, Kunal
|
|
|
14 |
5 |
p. 929-931
|
artikel
|
| 24 |
Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report
|
Nouhjah, Sedigheh
|
|
|
14 |
5 |
p. 731-732
|
artikel
|
| 25 |
Clinical spectrum, etiology and outcome of infectious disease emergencies in adult diabetic patients in northern India
|
Pannu, Ashok Kumar
|
|
|
14 |
5 |
p. 921-925
|
artikel
|
| 26 |
Clustering of noncommunicable disease risk factors among adults (18–69 years) in rural population, South-India
|
Sarveswaran, Gokul
|
|
|
14 |
5 |
p. 1005-1014
|
artikel
|
| 27 |
Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic”
|
Ferrario, Carlos M.
|
|
|
14 |
5 |
p. 1401-1402
|
artikel
|
| 28 |
“Comparison of cardiovascular autonomic activity (heart rate variability and baroreceptor sensitivity) in young healthy females during fasting and hyperglycaemia”
|
Majeed, Farrukh
|
|
|
14 |
5 |
p. 1511-1518
|
artikel
|
| 29 |
“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey"
|
Gangopadhyay, Kalyan Kumar
|
|
|
14 |
5 |
p. 1413-1418
|
artikel
|
| 30 |
Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events
|
Nandy, Kunal
|
|
|
14 |
5 |
p. 1017-1025
|
artikel
|
| 31 |
Corrigendum to “Vitamin D concentrations and COVID-19 infection in UK Biobank” [Diabetes Metabol Syndr: Clin Res Rev 2020 14 (4) 561–5]
|
Hastie, Claire E.
|
|
|
14 |
5 |
p. 1315-1316
|
artikel
|
| 32 |
COVID-19 and addiction
|
Dubey, Mahua Jana
|
|
|
14 |
5 |
p. 817-823
|
artikel
|
| 33 |
COVID-19 and applications of smartphone technology in the current pandemic
|
Iyengar, Karthikeyan
|
|
|
14 |
5 |
p. 733-737
|
artikel
|
| 34 |
COVID-19 and ethnicity: A novel pathophysiological role for inflammation
|
Vepa, Abhinav
|
|
|
14 |
5 |
p. 1043-1051
|
artikel
|
| 35 |
COVID-19 and self-care strategies for women with gestational diabetes mellitus
|
Moradi, Fatemeh
|
|
|
14 |
5 |
p. 1535-1539
|
artikel
|
| 36 |
COVID 19 could trigger global diabetes burden – A hypothesis
|
Mukherjee, Sandip
|
|
|
14 |
5 |
p. 963-964
|
artikel
|
| 37 |
COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India
|
Gopalan, Hema S.
|
|
|
14 |
5 |
p. 757-759
|
artikel
|
| 38 |
COVID-19 pandemic and its recovery time of patients in India: A pilot study
|
Barman, Manash Pratim
|
|
|
14 |
5 |
p. 1205-1211
|
artikel
|
| 39 |
Data-driven modelling and prediction of COVID-19 infection in India and correlation analysis of the virus transmission with socio-economic factors
|
Kumar, Amit
|
|
|
14 |
5 |
p. 1231-1240
|
artikel
|
| 40 |
Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic
|
Radanliev, Petar
|
|
|
14 |
5 |
p. 1121-1132
|
artikel
|
| 41 |
Decreased levels and activity of Sirt1 are modulated by increased miR-34a expression in adipose tissue mononuclear cells from subjects with overweight and obesity: A pilot study
|
Briones-Espinoza, Margarita J.
|
|
|
14 |
5 |
p. 1347-1354
|
artikel
|
| 42 |
Diabetes care during COVID 19: Experience in telemedicine from a developing country
|
García-Villasante, Eilhart
|
|
|
14 |
5 |
p. 1519
|
artikel
|
| 43 |
Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review
|
Wicaksana, Anggi Lukman
|
|
|
14 |
5 |
p. 1109-1120
|
artikel
|
| 44 |
Diabetes mellitus and the impairment of male reproductive function: Possible signaling pathways
|
Barkabi-Zanjani, Sona
|
|
|
14 |
5 |
p. 1307-1314
|
artikel
|
| 45 |
Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature
|
Reddy, Pavan Kumar
|
|
|
14 |
5 |
p. 1459-1462
|
artikel
|
| 46 |
Dietary habits and the 10-year risk of overweight and obesity in urban adult population: A cohort study predicated on Yazd Healthy Heart Project
|
Sarebanhassanabadi, Mohammadtaghi
|
|
|
14 |
5 |
p. 1391-1397
|
artikel
|
| 47 |
Differential mortality in COVID-19 patients from India and western countries
|
Jain, Vijay Kumar
|
|
|
14 |
5 |
p. 1037-1041
|
artikel
|
| 48 |
“Does having diabetes increase chances of contracting COVID-19 infection?”
|
Gangopadhyay, Kalyan Kumar
|
|
|
14 |
5 |
p. 765-766
|
artikel
|
| 49 |
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
|
Singh, Awadhesh Kumar
|
|
|
14 |
5 |
p. 725-727
|
artikel
|
| 50 |
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
|
Hariyanto, Timotius Ivan
|
|
|
14 |
5 |
p. 1463-1465
|
artikel
|
| 51 |
Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis
|
Ansari-Moghaddam, Alireza
|
|
|
14 |
5 |
p. 1101-1108
|
artikel
|
| 52 |
Editorial Board
|
|
|
|
14 |
5 |
p. i-ii
|
artikel
|
| 53 |
Effectiveness of customized insoles on maximum plantar pressure in diabetic foot syndrome: A systematic review
|
Korada, Hrishikesh
|
|
|
14 |
5 |
p. 1093-1099
|
artikel
|
| 54 |
Effect of Atorvastatin on blood ketone levels and glycemic control in patients with type 2 diabetes mellitus: A single arm pilot study
|
Baul, Priyanka Basu
|
|
|
14 |
5 |
p. 1333-1337
|
artikel
|
| 55 |
Effect of augmented glycation in mobilization of plasma free fatty acids in type 2 diabetes mellitus
|
Chandra, Kailash
|
|
|
14 |
5 |
p. 1385-1389
|
artikel
|
| 56 |
Effect of maternal perceived stress during pregnancy on gestational diabetes mellitus risk: A prospective case-control study
|
Mishra, Surabhi
|
|
|
14 |
5 |
p. 1163-1169
|
artikel
|
| 57 |
Effect of photobiomodulation on serum neuron specific enolase (NSE) among patients with diabetic peripheral neuropathy – A pilot study
|
M., Anju
|
|
|
14 |
5 |
p. 1061-1063
|
artikel
|
| 58 |
Effect of sertraline in patients with newly diagnosed depression and type 2 diabetes mellitus or hypertension: An observational study from south India
|
Padmapriya, C.
|
|
|
14 |
5 |
p. 1065-1068
|
artikel
|
| 59 |
Effects of garlic supplementation on serum inflammatory markers: A systematic review and meta-analysis of randomized controlled trials
|
Mirzavandi, Farhang
|
|
|
14 |
5 |
p. 1153-1161
|
artikel
|
| 60 |
Effects of low fructose diet on glycemic control, lipid profile and systemic inflammation in patients with type 2 diabetes: A single-blind randomized controlled trial
|
Jalilvand, Arman
|
|
|
14 |
5 |
p. 849-855
|
artikel
|
| 61 |
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
|
Ghosh, Amerta
|
|
|
14 |
5 |
p. 917-920
|
artikel
|
| 62 |
Effects of the Lysulin™ supplementation on pre-diabetes: A randomized double-blind, placebo-controlled clinical trial
|
Ranasinghe, Priyanga
|
|
|
14 |
5 |
p. 1479-1486
|
artikel
|
| 63 |
Erratum to “Letter to editor in response to “COVID-19: From bench to bedside” by Singh A et al.” [Diabetes & Metab Syndrome: Clin Res Rev 14 (5) (2020) 815–816 of duplicate article]
|
Singh, Harpreet
|
|
|
14 |
5 |
p. 1597
|
artikel
|
| 64 |
Established and novel gender dimorphisms in type 2 diabetes mellitus: Insights from a multiethnic cohort
|
Hermans, Michel P.
|
|
|
14 |
5 |
p. 1503-1509
|
artikel
|
| 65 |
Executive dysfunction in COVID-19 patients
|
Ardila, Alfredo
|
|
|
14 |
5 |
p. 1377-1378
|
artikel
|
| 66 |
Fighting infodemic: Need for robust health journalism in India
|
Sharma, D.C.
|
|
|
14 |
5 |
p. 1445-1447
|
artikel
|
| 67 |
Gender differences in the modifiable risk factors associated with the presence of prediabetes: A systematic review
|
Siddiqui, Sania
|
|
|
14 |
5 |
p. 1243-1252
|
artikel
|
| 68 |
Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
|
Wijaya, Indra
|
|
|
14 |
5 |
p. 1241-1242
|
artikel
|
| 69 |
Hypoglycemia at the time of Covid-19 pandemic
|
Shah, Kiran
|
|
|
14 |
5 |
p. 1143-1146
|
artikel
|
| 70 |
I believe community pharmacists can contribute in the early screening and referral of patients at risk for metabolic syndrome. Do you?
|
Rajanandh, M.G.
|
|
|
14 |
5 |
p. 1291
|
artikel
|
| 71 |
Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis
|
Salunke, Abhijeet Ashok
|
|
|
14 |
5 |
p. 1431-1437
|
artikel
|
| 72 |
Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals
|
Chudasama, Yogini V.
|
|
|
14 |
5 |
p. 965-967
|
artikel
|
| 73 |
Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus
|
Verma, Anjali
|
|
|
14 |
5 |
p. 1213-1216
|
artikel
|
| 74 |
Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India
|
Krishnakumar, Sneha
|
|
|
14 |
5 |
p. 1379-1383
|
artikel
|
| 75 |
Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia
|
Alshareef, Reem
|
|
|
14 |
5 |
p. 1583-1587
|
artikel
|
| 76 |
Improvement in Angiotensin 1-7 precedes and correlates with improvement in Arterial stiffness and endothelial function following Renin-Angiotensin system inhibition in type 2 diabetes with newly diagnosed hypertension
|
Srivastava, Prachi
|
|
|
14 |
5 |
p. 1253-1263
|
artikel
|
| 77 |
Improving clinical outcomes of diabetic foot ulcers by the 3-month self- and family management support programs in Indonesia: A randomized controlled trial study
|
Subrata, Sumarno Adi
|
|
|
14 |
5 |
p. 857-863
|
artikel
|
| 78 |
Incidence of diabetic nephropathy in patients with type 2 diabetes mellitus at a tertiary healthcare setting in Ethiopia
|
Tamru, Kidist
|
|
|
14 |
5 |
p. 1077-1083
|
artikel
|
| 79 |
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
|
Ghosal, Samit
|
|
|
14 |
5 |
p. 949-952
|
artikel
|
| 80 |
Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database
|
N, Vasantha Raju
|
|
|
14 |
5 |
p. 1171-1178
|
artikel
|
| 81 |
Intra-abdominal fat estimation by bio-electrical impedance analysis in patients with fibrocalculous pancreatic diabetes compared with BMI matched type 2 diabetic subjects and healthy controls
|
Shivaprasad, Channabasappa
|
|
|
14 |
5 |
p. 789-795
|
artikel
|
| 82 |
Is elephant foot yam (Amorphophallus paeoniifolius) tuber detrimental to patients with diabetes? (Or a myth?)
|
Rahman, Shaikh Shahinur
|
|
|
14 |
5 |
p. 1015-1016
|
artikel
|
| 83 |
Is it the COVID-19 happy hypoxia syndrome or the COVID 19 infodemic syndrome?
|
Sahu, Dipit
|
|
|
14 |
5 |
p. 1399
|
artikel
|
| 84 |
Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19?
|
Permana, Hikmat
|
|
|
14 |
5 |
p. 947-948
|
artikel
|
| 85 |
Lactobacillus rhamnosus GG and HbA1c in middle age and older adults without type 2 diabetes mellitus: A preliminary randomized study
|
Sanborn, Victoria E.
|
|
|
14 |
5 |
p. 907-909
|
artikel
|
| 86 |
Learning opportunities from COVID-19 and future effects on health care system
|
Iyengar, Karthikeyan
|
|
|
14 |
5 |
p. 943-946
|
artikel
|
| 87 |
Letter in response to letter to the editor by Singh and Dhibar regarding the article “COVID-19: From bench to bedside” (Singh et al.)
|
Singh, Akriti
|
|
|
14 |
5 |
p. 865
|
artikel
|
| 88 |
Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
|
Mahajan, Kunal
|
|
|
14 |
5 |
p. 723-724
|
artikel
|
| 89 |
Letter in response to the article “Enhancing immunity in viral infections, with special emphasis on COVID-19: A review” (Jayawardena et al.)
|
Santacroce, Luigi
|
|
|
14 |
5 |
p. 927
|
artikel
|
| 90 |
Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.)
|
Grant, W.B.
|
|
|
14 |
5 |
p. 893-894
|
artikel
|
| 91 |
Letter to editor in response to article “COVID-19: From bench to bedside” (Singh et al.)
|
Singh, Harpreet
|
|
|
14 |
5 |
p. 807
|
artikel
|
| 92 |
Letter to editor in response to “COVID-19: From bench to bedside” by Singh A et al.
|
Singh, Harpreet
|
|
|
14 |
5 |
p. 815-816
|
artikel
|
| 93 |
Letter to the editor in response to: COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India (Gopalan and Misra)
|
Pratap Singh, Ravi
|
|
|
14 |
5 |
p. 841-842
|
artikel
|
| 94 |
Letter to the Editor in response to the article: “Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis” (Ghoshal et al.)
|
Chand, Raj
|
|
|
14 |
5 |
p. 1305
|
artikel
|
| 95 |
Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”
|
Kumar Singh, Awadhesh
|
|
|
14 |
5 |
p. 937-938
|
artikel
|
| 96 |
Management of diabetic dyslipidemia: Navigating the new American and European Guidelines
|
Jialal, Ishwarlal
|
|
|
14 |
5 |
p. 877-879
|
artikel
|
| 97 |
Managing common endocrine disorders amid COVID-19 pandemic
|
Pal, Rimesh
|
|
|
14 |
5 |
p. 767-771
|
artikel
|
| 98 |
Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
|
Sharma, Praveen
|
|
|
14 |
5 |
p. 825-827
|
artikel
|
| 99 |
Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: A systematic review and meta-analysis
|
Shiferaw, Wondimeneh Shibabaw
|
|
|
14 |
5 |
p. 1403-1411
|
artikel
|
| 100 |
Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies
|
Costa, Fernanda Farias
|
|
|
14 |
5 |
p. 809-814
|
artikel
|
| 101 |
Multimorbidity and SARS-CoV-2 infection in UK Biobank
|
Chudasama, Yogini V.
|
|
|
14 |
5 |
p. 775-776
|
artikel
|
| 102 |
Necrotizing soft tissue infection of the upper extremities in patients with diabetes mellitus in a tertiary care center-a retrospective study
|
Naik, Dukhabandhu
|
|
|
14 |
5 |
p. 1071-1075
|
artikel
|
| 103 |
Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences
|
Lahiri, Durjoy
|
|
|
14 |
5 |
p. 1053-1060
|
artikel
|
| 104 |
Nonalcoholic fatty liver disease in males with low testosterone concentrations
|
Polyzos, Stergios A.
|
|
|
14 |
5 |
p. 1571-1577
|
artikel
|
| 105 |
Phytosterol supplements do not inhibit dipeptidyl peptidase-4
|
Gupta, Ankit
|
|
|
14 |
5 |
p. 1475-1478
|
artikel
|
| 106 |
Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them
|
Iyengar, Karthikeyan
|
|
|
14 |
5 |
p. 797-799
|
artikel
|
| 107 |
Predicting metabolic syndrome by anthropometric measures among adults 35–65 years in the west of Iran; a cross sectional study from an Iranian RaNCD cohort data
|
Hamzeh, Behrooz
|
|
|
14 |
5 |
p. 1293-1298
|
artikel
|
| 108 |
Prediction of new active cases of coronavirus disease (COVID-19) pandemic using multiple linear regression model
|
Rath, Smita
|
|
|
14 |
5 |
p. 1467-1474
|
artikel
|
| 109 |
Predictive performance of traditional and novel lipid combined anthropometric indices to identify prediabetes
|
Ramdas Nayak, Vineetha K.
|
|
|
14 |
5 |
p. 1265-1272
|
artikel
|
| 110 |
Prevalence and correlates of the metabolic syndrome in a cross-sectional community-based sample of 18–100 year-olds in Morocco: Results of the first national STEPS survey in 2017
|
Pengpid, Supa
|
|
|
14 |
5 |
p. 1487-1493
|
artikel
|
| 111 |
Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population
|
Anupam, Biswas
|
|
|
14 |
5 |
p. 1299-1304
|
artikel
|
| 112 |
Prevalence of metabolic syndrome and associated risk factors among tribal adolescents of Gujarat
|
Mahajan, Nupur
|
|
|
14 |
5 |
p. 995-999
|
artikel
|
| 113 |
Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil
|
do Vale Moreira, Nayla Cristina
|
|
|
14 |
5 |
p. 1217-1224
|
artikel
|
| 114 |
Prevalence of nephropathy in patients with type 2 diabetes in Iran: A systematic review and meta-analysis based on geographic information system (GIS)
|
Rabieenia, Elham
|
|
|
14 |
5 |
p. 1543-1550
|
artikel
|
| 115 |
Prevalence of type 2 diabetes mellitus (T2DM) in India: A systematic review (1994–2018)
|
Atre, Sachin
|
|
|
14 |
5 |
p. 897-906
|
artikel
|
| 116 |
Prevention of adolescent obesity: The global picture and an indian perspective
|
Srivastav, Prateek
|
|
|
14 |
5 |
p. 1195-1204
|
artikel
|
| 117 |
Professor Jitendra Nath Pande: Obituaries
|
|
|
|
14 |
5 |
p. 981-982
|
artikel
|
| 118 |
Projections for COVID-19 pandemic in India and effect of temperature and humidity
|
Goswami, Kuldeep
|
|
|
14 |
5 |
p. 801-805
|
artikel
|
| 119 |
Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings
|
Goyal, Alpesh
|
|
|
14 |
5 |
p. 753-756
|
artikel
|
| 120 |
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
|
Subir, Ray
|
|
|
14 |
5 |
p. 1225-1229
|
artikel
|
| 121 |
Psychosocial impact of COVID-19
|
Dubey, Souvik
|
|
|
14 |
5 |
p. 779-788
|
artikel
|
| 122 |
Redefining diabetic foot disease management service during COVID-19 pandemic
|
Jaly, Ibrahim
|
|
|
14 |
5 |
p. 833-838
|
artikel
|
| 123 |
Relationship between COVID-19 and obesity
|
Ekiz, Timur
|
|
|
14 |
5 |
p. 761-763
|
artikel
|
| 124 |
Relationship between the short stature and the prevalence of metabolic syndrome and insulin resistance markers in workers of a private educational institution in Peru
|
Toro-Huamanchumo, Carlos J.
|
|
|
14 |
5 |
p. 1339-1345
|
artikel
|
| 125 |
Renal changes and estimation of glomerular filtration rate using different equations in morbidly obese Egyptian patients
|
Bassiony, Amir I.
|
|
|
14 |
5 |
p. 1187-1193
|
artikel
|
| 126 |
Reply to Chand et al. regarding letter to the Editor regarding the article: ‘Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)’
|
Ghoshal, Samit
|
|
|
14 |
5 |
p. 1541
|
artikel
|
| 127 |
Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
|
Singh, Awadhesh Kumar
|
|
|
14 |
5 |
p. 729
|
artikel
|
| 128 |
Reply to the letter of Singh and Singh in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis” (Kumar et al.)
|
Kumar, Ashish
|
|
|
14 |
5 |
p. 1147-1148
|
artikel
|
| 129 |
Resolution of Metabolic syndrome with reduction of visceral adipose tissue in a 47 year old patient with Type 2 Diabetes Mellitus
|
Dembrowski, Gerald C.
|
|
|
14 |
5 |
p. 1001-1004
|
artikel
|
| 130 |
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: ‘Multimorbidity and SARS-CoV-2 infection in UK Biobank’ (Chudasama et al.)
|
Chudasama, Yogini V
|
|
|
14 |
5 |
p. 1281
|
artikel
|
| 131 |
Response to ‘Multimorbidity and SARS-CoV-2 infection in UK biobank’
|
Sur Roy, Abhipsha
|
|
|
14 |
5 |
p. 969
|
artikel
|
| 132 |
Response to the letter of L. Santacroce regarding article “Enhancing immunity in viral infections, with special emphasis on COVID-19: A review” (Jayawardena et al.)
|
Jayawardena, Ranil
|
|
|
14 |
5 |
p. 839
|
artikel
|
| 133 |
Response to ‘Vitamin D concentrations and COVID-19 infection in UK Biobank’
|
Roy, Akangsha Sur
|
|
|
14 |
5 |
p. 777
|
artikel
|
| 134 |
Reverse quarantine and COVID-19
|
Raveendran, A.V.
|
|
|
14 |
5 |
p. 1323-1325
|
artikel
|
| 135 |
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
|
Singh, Awadhesh Kumar
|
|
|
14 |
5 |
p. 971-978
|
artikel
|
| 136 |
SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity
|
Yadav, Rakhee
|
|
|
14 |
5 |
p. 1355-1360
|
artikel
|
| 137 |
Skeletal muscle – A bystander or influencer of metabolic syndrome?
|
Richter-Stretton, Gina L.
|
|
|
14 |
5 |
p. 867-875
|
artikel
|
| 138 |
Stress, glucocorticoid signaling pathway, and metabolic disorders
|
de Guia, Roldan M.
|
|
|
14 |
5 |
p. 1273-1280
|
artikel
|
| 139 |
Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians
|
|
|
|
14 |
5 |
p. 1579-1581
|
artikel
|
| 140 |
Teledentistry during COVID-19 pandemic
|
Ghai, Suhani
|
|
|
14 |
5 |
p. 933-935
|
artikel
|
| 141 |
Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review
|
Nouhjah, Sedigheh
|
|
|
14 |
5 |
p. 939-942
|
artikel
|
| 142 |
The burden of metabolic syndrome in patients living with HIV/AIDS receiving care at referral hospitals of Northwest Ethiopia: A hospital-based cross-sectional study, 2019
|
Gebrie, Alemu
|
|
|
14 |
5 |
p. 1551-1556
|
artikel
|
| 143 |
The effectiveness of pistachio on glycemic control and insulin sensitivity in patients with type 2 diabetes, prediabetes and metabolic syndrome: A systematic review and meta-analysis
|
Nowrouzi-Sohrabi, Peyman
|
|
|
14 |
5 |
p. 1589-1595
|
artikel
|
| 144 |
The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies
|
Nikpayam, Omid
|
|
|
14 |
5 |
p. 1521-1528
|
artikel
|
| 145 |
The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis
|
Tahapary, Dicky L.
|
|
|
14 |
5 |
p. 1559-1570
|
artikel
|
| 146 |
The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era
|
Lim, Michael Anthonius
|
|
|
14 |
5 |
p. 895-896
|
artikel
|
| 147 |
The prevalence and concerns of polycystic ovary syndrome in young female university students aged 18–25 in Trinidad
|
Nayak, B.S.
|
|
|
14 |
5 |
p. 1557-1558
|
artikel
|
| 148 |
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
|
Pranata, Raymond
|
|
|
14 |
5 |
p. 983-990
|
artikel
|
| 149 |
Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection
|
Hariyanto, Timotius Ivan
|
|
|
14 |
5 |
p. 1429-1430
|
artikel
|
| 150 |
Tools to manage medical uncertainty
|
Ghosh, Amit K.
|
|
|
14 |
5 |
p. 1529-1533
|
artikel
|
| 151 |
Tuberculosis in the era of COVID-19 in India
|
Jain, Vijay Kumar
|
|
|
14 |
5 |
p. 1439-1443
|
artikel
|
| 152 |
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
|
Jagat J, Mukherjee
|
|
|
14 |
5 |
p. 829-831
|
artikel
|
| 153 |
Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges
|
Badgujar, Kirtikumar C.
|
|
|
14 |
5 |
p. 1361-1376
|
artikel
|
| 154 |
Vitamin D deficiency in patients with diabetes and COVID- 19 infection
|
Singh, S.K.
|
|
|
14 |
5 |
p. 1033-1035
|
artikel
|
Tijdschrift beschrijving